Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |